Table 3 Long-term follow-up functional outcomes
Month(s) after revision | Uncemented THA (n = 116) | Hybrid THA (n = 120) | P-value |
|---|---|---|---|
1 | 81.2 ± 13.3 | 81.4 ± 12.4 | 0.102 |
6 | 83.5 ± 13.5 | 84.2 ± 11.3 | 0.136 |
12 | 84.6 ± 14.7 | 84.5 ± 13.2 | 0.213 |
24 | 85.6 ± 14.4 | 86.8 ± 12.8 | 0.372 |
36 | 87.4 ± 13.0 | 88.4 ± 11.4 | 0.291 |
48 | 89.8 ± 9.4 | 90.1 ± 9.2 | 0.106 |
60 | 88.9 ± 9.3 | 90.6 ± 9.3 | 0.116 |
72 | 86.2 ± 11.2 | 89.3 ± 9.5 | 0.027* |
84 | 82.7 ± 12.6 | 87.7 ± 10.7 | 0.015* |
96 | 81.5 ± 11.4 | 86.9 ± 11.6 | 0.032* |
108 | 80.1 ± 12.7 | 86.3 ± 11.2 | 0.012* |
120 | 78.6 ± 13.4 | 85.6 ± 12.1 | 0.017* |
Final follow-up | 77.4 ± 13.1 | 85.2 ± 12.3 | 0.014* |